Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

Simple Summary: Prognostic assessment in metastatic renal cell carcinoma may be improved by incorporating simple markers that reflect both tumor-related systemic inflammation and the general condition of the patient. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score combines routinely m...

Full description

Bibliographic Details

Published in:	Cancers Vol. 18; no. 13; pp. 2127 - 2141
Main Authors:	Günaltılı, Murat, Bölek, Hatice, Kaplan Tüzün, Esma, Usta, Sura, Efil, Safa Can, Akkus, Aysun Fatma, Işık, Selver, Kapar, Caner, Sekmek, Serhat, Güzel, Halil Göksel, Guliyev, Murad, Ozudogru, Talha, Göksu, Sema Sezin, Sever, Özlem Nuray, Arslan, Çagatay, Karadurmuş, Nuri, Sendur, Mehmet Ali Nahit, Tural, Deniz, Özgüroğlu, Mustafa, Yekedüz, Emre
Format:	research tables/charts Journal Article
Published:	MDPI Jul2026
Online Access:	View this record in EBSCOhost